Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells.

Protection against equine herpesvirus type 1 (EHV-1) infection in a mouse model has been studied by means of delayed-type hypersensitivity (DTH) and adoptive transfer of immune spleen cells. Mice were found to develop a positive DTH response to EHV-1 antigen which was sustained for several months after primary inoculation. The response was found to cross-react with EHV-4-derived antigen. Immune cells (from mice primed with live or heat-inactivated EHV-1) conferred an enhanced DTH response on recipients; however, only the immune cells that were previously primed with live EHV-1 gave protection against re-infection. The degree of protection was also dependent on the number of spleen cells transferred. Immune cells from mice primed with heat-inactivated EHV-1 appeared to enhance virus replication following subsequent inoculation. The serum antibody response to EHV-1 appeared to be slightly suppressed in recipients of spleen cells from mice primed with either live or heat-inactivated virus. These results support the important role for cell-mediated responses in protective immunity to EHV-1 and provide clues to the nature of protection and immunopathology in the natural host.

[1]  A. Awan,et al.  A murine model for studying EHV-1-induced abortion. , 1991, Research in veterinary science.

[2]  A. Awan,et al.  The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. , 1990, The Journal of general virology.

[3]  A. Collins Equine herpesvirus , 1989, Veterinary Record.

[4]  G. Allen,et al.  A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. , 1989, The Journal of general virology.

[5]  E. Schiltknecht,et al.  In vivo effects of cyclosporine in the generation and expression of effector cell function. , 1986, Transplantation Proceedings.

[6]  Bryans Jt,et al.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. , 1986 .

[7]  G. Allen,et al.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. , 1986, Progress in veterinary microbiology and immunology.

[8]  A. Nash,et al.  Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. , 1981, Immunology.

[9]  R. Mock,et al.  Vaccination of pregnant ponies against equine rhinopneumonitis. , 1980, American Journal of Veterinary Research.

[10]  A. Nash,et al.  Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. , 1980, The Journal of general virology.

[11]  P. Clapham,et al.  Serological detection of equid herpesvirus 1 infections of the respiratory tract. , 1976, Equine veterinary journal.

[12]  A. Corner,et al.  Meningoencephalomyelitis in Horses Associated with Equine Herpesvirus 1 Infection , 1976, Veterinary pathology.